Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Dapagliflozin in T1DM with Automated Insulin Pump
NCT06922656Phase 4Not yet recruiting
- Sponsor
- Dasman Diabetes Institute
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of pioglitazone in type 1 diabetes mellitus (T1D), sponsored by Dasman Diabetes Institute. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
pioglitazone
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06922656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06922656.